efÀcacy determinants of subcutaneous microdose glucagon during

17
(IÀFDF\ 'HWHUPLQDQWV RI 6XEFXWDQHRXV 0LFURGRVH *OXFDJRQ GXULQJ &ORVHG/RRS &RQWURO 6WHYHQ - 5XVVHOO 0' 3K' )LUDV + (O.KDWLE 3K' 'DYLG 0 1DWKDQ 0' DQG (GZDUG 5 'DPLDQR 3K' $XWKRU $IÀOLDWLRQV 'LDEHWHV 8QLW DQG 'HSDUWPHQW RI 0HGLFLQH 0DVVDFKXVHWWV *HQHUDO +RVSLWDO DQG +DUYDUG 0HGLFDO 6FKRRO %RVWRQ 0DVVDFKXVHWWV DQG 'HSDUWPHQW RI %LRPHGLFDO (QJLQHHULQJ %RVWRQ 8QLYHUVLW\ %RVWRQ 0DVVDFKXVHWWV $EEUHYLDWLRQV %* EORRG JOXFRVH 03& PRGHO SUHGLFWLYH FRQWURO 3' SURSRUWLRQDO GHULYDWLYH 3. SKDUPDFRNLQHWLF .H\ZRUGV DUWLÀ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ÀHG DQG DQDO\]HG HSLVRGHV GXULQJ ZKLFK JOXFDJRQ ZDV JLYHQ DQG FDWHJRUL]HG WKHP DV HLWKHU VXFFHVVIXO RU XQVXFFHVVIXO LQ SUHYHQWLQJ K\SRJO\FHPLD 5HVXOWV ,Q RI WKH HSLVRGHV JOXFDJRQ DGPLQLVWUDWLRQ SUHYHQWHG K\SRJO\FHPLD ,Q WKH UHPDLQLQJ %* IHOO EHORZ PJGO RI WKH RFFXUUHG GXULQJ H[SHULPHQWV SHUIRUPHG EHIRUH 3. SDUDPHWHUV ZHUH DGMXVWHG 7KH GLPHQVLRQOHVV OHYHOV RI SODVPD LQVXOLQ QRUPDOL]HG UHODWLYH WR HDFK VXEMHFW·V EDVHOLQH LQVXOLQ OHYHO ZHUH VLJQLÀFDQWO\ KLJKHU GXULQJ HSLVRGHV HQGLQJ LQ K\SRJO\FHPLD YHUVXV WLPHV WKH EDVHOLQH LQVXOLQ OHYHO S 7KH UHODWLYH HUURU LQ WKH FRQWURO DOJRULWKP·V RQOLQH HVWLPDWH RI WKH LQVWDQWDQHRXV SODVPD LQVXOLQ OHYHO ZDV DOVR KLJKHU GXULQJ HSLVRGHV HQGLQJ LQ K\SRJO\FHPLD YHUVXV S DV ZHUH WKH SHDN SODVPD JOXFDJRQ OHYHOV YHUVXV SJPO S QRUPDO UDQJH ² SJPO DQG PHDQ SODVPD JOXFDJRQ OHYHOV YHUVXV SJPO S 5HODWLYH WR PHDQ SODVPD LQVXOLQ OHYHOV PHDQ SODVPD JOXFDJRQ OHYHOV WHQGHG WR EH KLJKHU GXULQJ HSLVRGHV HQGLQJ LQ K\SRJO\FHPLD DOWKRXJK WKLV UHVXOW ZDV QRW IRXQG WR EH VWDWLVWLFDOO\ VLJQLÀFDQW S 7KH UDWH RI %* GHVFHQW ZDV DOVR VLJQLÀFDQWO\ JUHDWHU GXULQJ HSLVRGHV HQGLQJ LQ K\SRJO\FHPLD YHUVXV PJGOPLQ S FRQWLQXHG 6<0326,80

Upload: doanthuy

Post on 11-Dec-2016

221 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 2: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 3: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 4: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 5: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 6: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 7: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 8: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 9: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 10: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 11: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 12: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 13: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 14: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 15: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 16: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during
Page 17: EfÀcacy Determinants of Subcutaneous Microdose Glucagon during